Overview

The 61st Annual Update: Obstetrics and Gynecology 2025 will be held March 7 – 12, 2025. You can attend online as the course is live streamed, or in person in Boston, MA. All sessions will be recorded and made available to all participants to view online, at your convenience.

Much has changed in the field of obstetrics and gynecology in the past year, with significant implications for clinicians. This special update on diagnosis and treatment of the reproductive health of women across their lifespan, designed and presented by Harvard Medical School’s leading faculty and master clinicians, ensures you are current with these changes.

Education is practical, offering updates and practice recommendations that you can immediately incorporate into daily practice to optimize patient care and outcomes.

Unique to this program is the ability to customize your learning experience for your specific areas of interest:

• Clinical obstetrics 
• Minimally invasive gynecologic surgery
• Urogynecology
• Gynecologic oncology 
• Reproductive endocrinology and infertility
• Adolescent gynecology
• Menopause management
• High-risk patients
• Difficult deliveries
• Advances in diagnostic equipment and techniques

Learning Objectives

Upon completion of the following activities, learners will be able to:

Clinical Obstetrics:

• Review evidence for interconception, antenatal surveillance and risk-reducing strategies, and suggest quality measures for care.
• Analyze the current management of maternal complications of pregnancy.
• Outline the role that obstetricians play in adverse neonatal outcomes.
• Develop treatment plans for the management of antepartum complications, including obstetric emergencies, cervical incompetence, and preterm labor.

Minimally Invasive Gynecologic Surgery, Urogynecology, and Gynecologic Oncology:

• Discuss practical tips in minimally invasive gynecology surgery
• Utilize current gynecologic surgical techniques, including laparoscopy and hysterectomy, and assess indications for use and how to manage complications.
• Choose the best surgical approach to avoid unintended outcomes.
• Analyze the latest trends in minimally invasive surgery and how they impact the care of the patient.
• Discuss techniques and best practices in the operating room for minimally invasive prolapse surgeries.
• Explore the historical transition of abdominal and vaginal surgery to minimally invasive surgery for pelvic organ prolapse
• Understand patient outcome data on minimally invasive surgeries for prolapse
• Manage patients with urinary incontinence and pelvic prolapse.
• Understand the evidence for behavioral therapies in managing overactive bladder; discuss medications, therapy specifics, adverse events, and management.
• Understand 3rd-line OAB therapies
• Review evidence in the use of slings and pessaries.
• Explain lower urinary tract physiology, pelvic anatomy, and vaginal hysterectomy.
• Develop new strategies to apply in practice for the management of neoplastic disorders and non-malignant conditions.
• Evaluate the non-surgical management of malignant and non-malignant gynecologic tumors.
• Identify neoplastic disorders and non-malignant conditions.
• Discuss the philosophy of opioid-free surgery.
• Describe features of a malignant adnexal mass to better define malignant risk.
• Discuss the rational use of tumor markers to focus on most valid results.

Infertility, Menopause, and Reproductive Endocrinology Objectives:

• Incorporate new management strategies for patients with endocrine and fertility disorders.
• Analyze advances in the field as they apply to the management of patients with endocrine and fertility disorders.
• Develop techniques to evaluate pelvic pain and bleeding, and strategies for managing them.
• Institute a therapeutic management plan for patients with non-menopause-related endocrine imbalance, as well as those who are menopausal and post-menopausal.
• Learn about all newer methods of reversible contraception.
• Recognize the major health concerns of menopausal women.

Additional Objectives:

• Understand the impact of individual, community, and structural factors on health outcomes of patients in OBGYN.
• Define health equity in OBGYN care and describe the unique roles of OBGYNs in ensuring it.
• Describe the strategies for assessing and addressing bias and health disparities in your own practice.

Target Audience

• Physicians specializing in obstetrics and gynecology, including:
• Obstetricians 
• Gynecologists
• Perinatologists
• Urogynecologists
• Gynecologic Oncologists
• Reproductive Endocrinologists
• Infertility Specialists
• Family Physicians
• Nurse Practitioners
• Physician Assistants

Accreditation

The Harvard Medical School designates this live activity for a maximum of 44.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Full Course: a maximum of 44.00 AMA PRA Category 1 Credits™
• Clinical Obstetrics (March 7–8): a maximum of 15.25 AMA PRA Category 1 Credits™
• Minimally Invasive Gynecologic Surgery, Urogynecology, and Gynecologic Oncology (March 9–10): a maximum of 14.75 AMA PRA Category 1 Credits™
• Infertility, Menopause, and Reproductive Endocrinology (March 11–12): a maximum of 14.00 AMA PRA Category 1 Credits™

For more information please visit the official event page.